Long-term stabilization of recombinant human interferon α 2b in aqueous solution without serum albumin
- 2 October 2003
- journal article
- Published by Elsevier BV in International Journal of Pharmaceutics
- Vol. 264 (1-2), 57-72
- https://doi.org/10.1016/s0378-5173(03)00388-0
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Cancer immunotherapy: The interferon-α experienceSeminars in Oncology, 2002
- Final Report on the Safety Assessment of Benzyl Alcohol, Benzoic Acid, and Sodium BenzoateInternational Journal of Toxicology, 2001
- Interferon Alfa-2b Alone or in Combination with Ribavirin for the Treatment of Relapse of Chronic Hepatitis CNew England Journal of Medicine, 1998
- “Inactive” Ingredients in Pharmaceutical Products: Update (Subject Review)PEDIATRICS, 1997
- The use of deferoxamine infusions to enhance the response rate to interferon‐α treatment of chronic viral hepatitis BJournal of Viral Hepatitis, 1996
- Treatment of Stage D2 Hormone Refractory Carcinoma of the Prostate with 5-Fluorouracil and Roferon-A®: A Southwest Oncology Group StudyCancer Biotherapy & Radiopharmaceuticals, 1996
- Changes of serum 2‘,5’‐oligoadenylate synthetase activity during interferon treatment of chronic hepatitis CLiver International, 1993
- Degradation of Fenprostalene in Polyethylene Glycol 400 SolutionJournal of Pharmaceutical Sciences, 1984
- The Gasping Syndrome and Benzyl Alcohol PoisoningNew England Journal of Medicine, 1982
- FATAL BENZYL ALCOHOL POISONING IN A NEONATAL INTENSIVE CARE UNITThe Lancet, 1982